Should mild or moderate stroke patients be admitted to an intensive care unit?

被引:84
作者
Briggs, DE
Felberg, RA
Malkoff, MD
Bratina, P
Grotta, JC
机构
[1] Univ Texas, Houston Sch Med, Dept Neurol, Houston, TX USA
[2] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA
关键词
costs and cost analysis; stroke; stroke management; stroke outcome; triage;
D O I
10.1161/01.STR.32.4.871
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Inhospital placement of patients with mild (National institutes of Health Stroke Scale [NIHSS] score <8) or moderate (NIHSS 8 through 16) acute strokes is variable. We assessed the outcome of such patients based on intensive care unit (ICU) versus general ward placement. Methods-We reviewed 138 consecutive patients admitted within 24 hours of stroke onset to 2 physically adjacent hospitals with different admitting practices. Outcome measures included complication rates, discharge Rankin scale score, hospital discharge placement, costs, and length of stay (LOS). Results-Hospital A, a 626-bed university-affiliated hospital, admitted 43% of mild and moderate strokes (MMS) to an ICU (26% of mild, 74% of moderate), whereas hospital B, a 618-bed community facility, admitted 18% of MMS to an ICU (3% of mild, 45% of moderate; P<0.004). There were no significant differences in outcomes between the 2 hospitals. Analysis of only patients admitted to hospital A, and of all patients, demonstrated that mild stroke patients admitted to the general ward had fewer complications and more favorable discharge Rankin scale scores than similar patients admitted to an ICU, There was no statistically significant difference in LOS, but total room costs for a patient admitted first to the ICU averaged $15 270 versus $3638 for admission directly to the ward. Conclusions-While limited by the retrospective nature of our study, routinely admitting acute MMS patients to an ICU provides no cost or outcomes benefits.
引用
收藏
页码:871 / 876
页数:6
相关论文
共 12 条
[1]   Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery - A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) [J].
Adams, HP ;
Bendixen, BH ;
Leira, E ;
Chang, KC ;
Davis, PH ;
Woolson, RF ;
Clarke, WR ;
Hansen, MD .
NEUROLOGY, 1999, 53 (01) :122-125
[2]   How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials [J].
Asplund, K ;
Berman, P ;
Blomstrand, C ;
Dennis, M ;
Erila, T ;
Garraway, M ;
Hamrin, E ;
Hankey, G ;
Ilmavirta, M ;
Indredavik, B ;
Kalra, L ;
Kaste, M ;
Langhorne, P ;
Rodgers, H ;
Sivenius, J ;
Slattery, J ;
Stevens, R ;
Svensson, A ;
Warlow, C ;
Williams, B ;
WoodDauphinee, S ;
Deleo, D ;
Drummond, A ;
Fogelholm, R ;
Lincoln, N ;
Palomaki, H ;
Strand, T ;
Wilhelmsen, L ;
Counsell, C ;
Fraser, H .
STROKE, 1997, 28 (11) :2139-2144
[3]   The Greater Cincinnati Northern Kentucky Stroke Study - Preliminary first-ever and total incidence rates of stroke among blacks [J].
Broderick, J ;
Brott, T ;
Kothari, R ;
Miller, R ;
Khoury, J ;
Pancioli, A ;
Gebel, J ;
Mills, D ;
Minneci, L ;
Shukla, R .
STROKE, 1998, 29 (02) :415-421
[4]   Predictors of acute hospital costs for treatment of ischemic stroke in an academic center [J].
Diringer, MN ;
Edwards, DF ;
Mattson, DT ;
Akins, PT ;
Sheedy, CW ;
Hsu, CY ;
Dromerick, AW .
STROKE, 1999, 30 (04) :724-728
[5]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[6]  
Holloway RG, 1996, NEUROLOGY, V46, P854
[7]   Stroke unit treatment improves long-term quality of life -: A randomized controlled trial [J].
Indredavik, B ;
Bakke, F ;
Slordahl, SA ;
Rokseth, R ;
Håheim, LL .
STROKE, 1998, 29 (05) :895-899
[8]   Reliability and validity of estimating the NIH Stroke Scale score from medical records [J].
Kasner, SE ;
Chalela, JA ;
Luciano, JM ;
Cucchiara, BL ;
Raps, EC ;
McGarvey, ML ;
Conroy, MB ;
Localio, AR .
STROKE, 1999, 30 (08) :1534-1537
[9]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[10]  
MATCHAR DB, 1994, STROKE CLIN UPDATES, V5, P9